U.S. Markets closed

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
13.29-0.19 (-1.41%)
At close: 3:56PM EDT
Full screen
Loading interactive chart...
  • Benzinga

    BWXT Medical, Bayer AG Ink Agreement On Actinium-225

    BWX Technologies Inc's (NYSE: BWXT) subsidiary BWXT Medical Ltd. has agreed with Bayer AG (OTC: BAYRY) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products. The financial terms of the agreement were not disclosed. The companies to broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other products. Ac-225 is a radioisotope used in targeted alpha therapies (TATs), an emerging class of radionuclide therapy

  • Business Wire

    Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Cavallo Ventures

    LEVERKUSEN, Germany & EMERYVILLE, Calif., September 14, 2021--Leaps by Bayer, the impact investment arm of Bayer AG, today announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongside existing investors KdT Ventures and Endurance.

  • Bloomberg

    Bayer Unit Makes More Investments to Curb Synthetic Fertilizers

    (Bloomberg) -- Bayer AG just made its second investment in as many months in startups working to curb the use of synthetic fertilizers, a step that would help the agricultural industry -- a major polluter -- become more environmentally friendly.The industry giant, which owns agrochemical and biotechnology company Monsanto Co., said Tuesday one of its units co-lead a $15 million investment in Andes, a startup that treats seeds so plants can better draw nitrogen from the air instead of needing ene